CIP
RXDX

Chartwell Investment Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Chartwell Investment Partners’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,408
Closed -$555K – 445
2022
Q3 		$555K Buy
+9,408
New +$555K 0.02% 381